07/21/2014 - 9:40am

Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.

07/18/2014 - 10:35am

The Food and Drug Administration on Thursday announced the approval of Ruconest, a recombinant C1-Esterase inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema.

07/17/2014 - 12:27pm

There is “something brewing in Congress” these days, NACDS president and CEO Steve Anderson wrote in a July 16 newsletter to NACDS chain members.

07/17/2014 - 10:49am

Diplomat announced it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin.

 

07/17/2014 - 10:01am

Purdue Pharma announced that the Food and Drug Administration approved a new 7.5-mcg/hour dosage strength of Butrans (buprenorphine) transdermal system CIII.

07/17/2014 - 9:34am

Mylan on Thursday announced that the U.S. District Court for the district of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline in relation to paroxetine CR, the generic version of GSK's Paxil CR.

07/16/2014 - 1:18pm

HelpAround on Wednesday launched a mobile platform for people with diabetes — and their friends, family and caregivers — that reveals fellow ‘diabetes helpers’ from the crowd, helping people resolve sudden health crises, such as getting caught without essential over-the-counter blood glucose test strips.

07/16/2014 - 12:52pm

Sun Life Assurance Company of Canada entered into a strategic business relationship with McKesson Canada to launch the Sun Life Preferred Pharmacy Network.

07/16/2014 - 12:24pm

GSK has begun shipping Fluarix Quadrivalent (influenza vaccine) doses to U.S. healthcare providers, the company annouced. This marks the first shipment of GSK's U.S. flu vaccine supply for the flu season, which follows licensing and lot-release approval from the Food and Drug Administration's Center for Biologics Evaluation and Research.